Similar articles

• Understanding the long-term benefits and dangers of intensive therapy of diabetes.

  Nathan DM. Nathan DM. Arch Intern Med. 2012 May 28;172(10):769-70. doi: 10.1001/archinternmed.2012.438. Arch Intern Med. 2012. PMID: 22636821 No abstract available.
• The authors reply:

  Perkovic V, Woodward M, Zoungas S, Chalmers J. Perkovic V, et al. Kidney Int. 2013 Sep;84(3):622. doi: 10.1038/ki.2013.241. Kidney Int. 2013. PMID: 23989363 No abstract available.
• Caution advised in interpreting nonsignificant results from ADVANCE post hoc analysis.

  Brar JE. Brar JE. Kidney Int. 2013 Sep;84(3):621-2. doi: 10.1038/ki.2013.239. Kidney Int. 2013. PMID: 23989359 No abstract available.
• Role of intensive glucose control in development of renal end points in type 2 diabetes mellitus: systematic review and meta-analysis intensive glucose control in type 2 diabetes.

  Coca SG, Ismail-Beigi F, Haq N, Krumholz HM, Parikh CR. Coca SG, et al. Arch Intern Med. 2012 May 28;172(10):761-9. doi: 10.1001/archinternmed.2011.2230. Arch Intern Med. 2012. PMID: 22636820 Free PMC article. Review.
• [Can diabetic nephropathy be prevented? Or what is the point of no return?].

  Grimaldi A, Baumelou A. Grimaldi A, et al. Ann Med Interne (Paris). 1987;138(7):483-5. Ann Med Interne (Paris). 1987. PMID: 3326450 Review. French. No abstract available.